Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Raptor Pharmaceutical Corp (NASDAQ:RPTP)

5.95
Delayed Data
As of 11:48am ET
 -0.11 / -1.82%
Today’s Change
2.94
Today|||52-Week Range
14.87
+14.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$517.0M

Company Description

Raptor Pharmaceutical Corp. engages as a global biopharmaceutical company, which is committed to the development and commercialization of life-altering therapeutics for orphan diseases. Its pipeline consists of potential treatments for neurodegenerative diseases, mitochondrial diseases, and lung infections. The company was founded by Christopher M. Starr and Todd C. Zankel on September 29, 2009 and is headquartered in Novato, CA.

Contact Information

Raptor Pharmaceutical Corp.
7 Hamilton Landing
Novato California 94949
P:(415) 408-6200
Investor Relations:

Employees

Shareholders

Other institutional33.68%
Mutual fund holders21.24%
Individual stakeholders21.22%

Top Executives

Julie Anne SmithPresident, Chief Executive Officer & Director
Michael P. SmithChief Financial Officer, Secretary & Treasurer
Todd C. ZankelChief Scientific Officer
Krishna R. PoluChief Medical Officer
Ashley C. GouldChief Legal & Compliance Officer, Senior VP